Entrectinib: a potent new TRK, ROS1, and ALK inhibitorChristian Rolfo, Luis E. Raez, Antonio Russo et al.|Expert Opinion on Investigational Drugs|2015Cited by 153
Curcumin inhibits<i>in vitro</i>and<i>in vivo</i>chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21Simona Taverna, Riccardo Alessandro, Marco Giallombardo et al.|Oncotarget|2015Cited by 138